Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ron Boon"'
Publikováno v:
Dermatology and Therapy
Introduction Antivirals and occlusive lip patches are key treatments for cold sores. Additional therapeutic options, and validated methods to evaluate these, are needed. Methods This exploratory, double-blind, single-center study aimed to evaluate a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34eac965abd4377215d6e3fafc685daf
http://europepmc.org/articles/PMC8163941
http://europepmc.org/articles/PMC8163941
Autor:
Teresa H. Bacon, Ron Boon, Adriana Weinberg, Spotswood L. Spruance, Mariann Bernard, Myron J. Levin, Young Kyoo Shin
Publikováno v:
The Journal of Infectious Diseases. 187:1241-1245
Subjects received topical penciclovir for 4 days during successive episodes of recurrent herpes labialis. Isolation of herpes simplex virus (HSV) was attempted from lesions obtained before initiation of treatment and on each day of therapy. Isolates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5e5e7ac8d19b2cf8af2437a23cddd6
https://doi.org/10.1086/373993
https://doi.org/10.1086/373993
Publikováno v:
Pharmacoepidemiology and Drug Safety. 11:373-378
Purpose To describe the effectiveness of community-based pharmacists in conducting a study to measure the baseline prevalence of Herpes simplex virus, type-1 susceptibility to two antiviral medications in subjects with recurrent Herpes labialis Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9663418979fbec36802179a900fe9dfb
https://doi.org/10.1002/pds.710
https://doi.org/10.1002/pds.710
Autor:
Ron Boon, G. Wayne Raborn, Alain Martel, Spotswood L. Spruance, Michael A.O. Lewis, Michel Lassonde
Publikováno v:
The Journal of the American Dental Association. 133:303-309
Background Two randomized, double-blind, parallel-group clinical trials were conducted in Europe and North America to compare the efficacy and safety of topical 1 percent penciclovir cream with a placebo cream. Methods A total of 4,573 immunocompeten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f873a459ae7ddd13fd4abd4fcf0a8d
https://doi.org/10.14219/jada.archive.2002.0169
https://doi.org/10.14219/jada.archive.2002.0169
Publikováno v:
Journal of Hepatology. 32:1011-1018
Background/Aims: Famciclovir, an orally available nucleoside analogue with potent in vitro activity against HBV, is being investigated for treatment of chronic hepatitis B. Methods: A dose-finding study was conducted in patients with hepatitis B e an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce2012d3fcb667f420d74654a1a53af
https://doi.org/10.1016/s0168-8278(00)80106-3
https://doi.org/10.1016/s0168-8278(00)80106-3
Publikováno v:
The Journal of Infectious Diseases. 178:S76-S80
New and previously reported analyses of the data from a placebo-controlled trial of famciclovir are reviewed in light of recently proposed recommendations for the analysis of pain in herpes zoster trials. The analyses examined the effect of famciclov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::634d3d4e89599a214c663c2377966e90
https://doi.org/10.1086/514260
https://doi.org/10.1086/514260
Autor:
Robin Saltzman, Ron Boon
Publikováno v:
Current Therapeutic Research. 56:219-225
Famciclovir is the well-absorbed oral form of the antiherpes agent penciclovir. Safety reports from clinical studies of more than 6500 patients and from spontaneous reports indicate that famciclovir is well tolerated. Safety data have been compiled f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fefcaff7d92b8a5408a4f6254ba99f7
https://doi.org/10.1016/0011-393x(95)85026-0
https://doi.org/10.1016/0011-393x(95)85026-0
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:2454-2457
Safety reporting from individual ongoing and completed clinical studies has demonstrated that famciclovir, the well-absorbed oral form of the antiherpesvirus agent penciclovir, has been well tolerated by more than 3,000 individuals worldwide. An inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0fb88f1d99dc1eb382e83e2c60d2e4
https://doi.org/10.1128/aac.38.10.2454
https://doi.org/10.1128/aac.38.10.2454
Autor:
K. M. Esser, Thanh D. Nguyen, Jeffry J. Leary, Robin Saltzman, Ron Boon, Matthew R. Quail, Karen Duffy, Teresa H. Bacon, Leslie A. Locke, Robert T. Sarisky
Publikováno v:
Archives of virology. 148(9)
Asusceptibility testing program was established to determine the prevalence of resistance to penciclovir among herpes simplex virus isolates collected from patients participating in 11 world-wide clinical trials involving penciclovir (topical or intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feaa9dd4e2e538693e0cab9fa9c29188
https://pubmed.ncbi.nlm.nih.gov/14505088
https://pubmed.ncbi.nlm.nih.gov/14505088
In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals with an episode of recurrent herpes labialis not treated with topical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beee212e4704bfa6331add9695e83fdc
https://europepmc.org/articles/PMC127455/
https://europepmc.org/articles/PMC127455/
